AbbVie
ABBV
#35
Rank
C$480.21 B
Marketcap
C$271.50
Share price
-1.11%
Change (1 day)
2.64%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): C$9.15 Billion

According to AbbVie's latest financial reports the company's current earnings are C$61.16 Billion. , an increase over its 2024 earnings that were of C$5.07 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 C$9.01 B77.53%
2024 C$5.07 B-40.54%
2023 C$8.53 B-53.62%
2022 C$18.41 B3.76%
2021 C$17.74 B282.25%
2020 C$4.64 B-59.67%
2019 C$11.51 B62.13%
2018 C$7.10 B-32.74%
2017 C$10.55 B-1.99%
2016 C$10.77 B18.65%
2015 C$9.07 B180.5%
2014 C$3.23 B-55.57%
2013 C$7.28 B-6.86%
2012 C$7.82 B56.05%
2011 C$5.01 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$13.92 B 54.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.15 B 290.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.26 B 36.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.12 B-76.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.38 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.74 B 41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$19.27 B 113.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.52 B 50.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$0.86 B-90.35%๐Ÿ‡บ๐Ÿ‡ธ USA